1-6 of 6
Günter Schlimok
Close
Sort by
Journal Articles

Allogeneic Hematopoietic Cell Transplantation in AML with Normal Karyotype and NPM1 Mutated FLT3-ITD Negative: A Retrospective Analysis from the Acute Leukemia Working Party of EBMT

Ali Bazarbachi, Myriam Labopin, MD, Mohamed A Kharfan-Dabaja, MD, Rainer Schwerdtfeger, MD, Liisa Volin, MD, Jean-Henri Bourhis, MD PhD, Gerard Socie, MD PhD, Eric Deconinck, Tobias Gedde-Dahl, MD PhD, Alessandro Rambaldi, MD, Pavel Jindra, MD PhD, Günter Schlimok, MD, Didier Blaise, MD PhD, Patrice Chevallier, MD PhD, Arnon Nagler, MD, Christoph Schmid, MD, Jordi Esteve, MD PhD, Mohamad Mohty, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1230.
https://doi.org/10.1182/blood.V124.21.1230.1230
Published: 2014
Journal Articles

Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy

Clinical Trials & Observations
Christian Straka, Michael Sandherr, Hans Salwender, Hannes Wandt, Bernd Metzner, Kai Hübel, Gerda Silling, Marcus Hentrich, Daniel Franke, Rainer Schwerdtfeger, Mathias Freund, Orhan Sezer, Alexander Giagounidis, Gerhard Ehninger, Wolfgang Grimminger, Andreas Engert, Günter Schlimok, Christof Scheid, Peter Hellmann, Harald Heinisch, Hermann Einsele, Axel Hinke, Bertold Emmerich
Journal: Blood
Blood (2011) 117 (7): 2121–2128.
https://doi.org/10.1182/blood-2010-06-290080
Published: 2011
Journal Articles

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

Brief Report
Felicitas Thol, Frederik Damm, Katharina Wagner, Gudrun Göhring, Brigitte Schlegelberger, Dieter Hoelzer, Michael Lübbert, Wolfgang Heit, Lothar Kanz, Günter Schlimok, Aruna Raghavachar, Walter Fiedler, Hartmut Kirchner, Gerhard Heil, Michael Heuser, Jürgen Krauter, Arnold Ganser
Journal: Blood
Blood (2010) 116 (4): 614–616.
https://doi.org/10.1182/blood-2010-03-272146
Published: 2010
Includes: Supplemental data
Journal Articles

Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV

Clinical Trials & Observations
Susanne Saussele, Michael Lauseker, Alois Gratwohl, Dietrich W. Beelen, Donald Bunjes, Rainer Schwerdtfeger, Hans-Jochem Kolb, Anthony D. Ho, Christiane Falge, Ernst Holler, Günter Schlimok, Axel R. Zander, Renate Arnold, Lothar Kanz, Robert Dengler, Claudia Haferlach, Brigitte Schlegelberger, Markus Pfirrmann, Martin C. Müller, Susanne Schnittger, Armin Leitner, Nadine Pletsch, Andreas Hochhaus, Joerg Hasford, Rüdiger Hehlmann, for the German CML Study Group
Journal: Blood
Blood (2010) 115 (10): 1880–1885.
https://doi.org/10.1182/blood-2009-08-237115
Published: 2010
Includes: Supplemental data
Journal Articles

Treatment of Patients up to 60 Years with High Risk AML: Final Results of the AML SHG-Hannover 01/99 Trial.

Jürgen Krauter, MD, Gerhard Heil, M.D., Dieter Hoelzer, M.D., Oliver G. Ottmann, M.D., Hans Martin, M.D., Michael Lubbert, M.D., Jurgen Finke, M.D., Wolfgang F.W. Heit, M.D., Walter Fiedler, M.D., Lothar Kanz, M.D., Gunter Schlimok, M.D., Hartmut H. Kirchner, M.D., Aruna Raghavachar, M.D., Wolfram Brugger, M.D., Arnold Ganser, M.D.
Journal: Blood
Blood (2006) 108 (11): 433.
https://doi.org/10.1182/blood.V108.11.433.433
Published: 2006
Journal Articles

Prospective Randomized Comparison of High Dose AraC and AutoPBSCT as Late Consolidation for Patients ≤60 Years with Standard Risk AML: Final Results of the AML SHG-Hannover 01/99 Trial.

Arnold Ganser, MD, Jürgen Krauter, M.D., Dieter Hoelzer, M.D., Oliver G. Ottmann, M.D., Hans Martin, M.D., Michael Lubbert, M.D., Jurgen Finke, M.D., Wolfgang F.W. Heit, M.D., Walter Fiedler, M.D., Lothar Kanz, M.D., Gunter Schlimok, M.D., Hartmut H. Kirchner, M.D., Aruna Raghavachar, M.D., Wolfram Brugger, M.D., Gerhard Heil, M.D.
Journal: Blood
Blood (2006) 108 (11): 607.
https://doi.org/10.1182/blood.V108.11.607.607
Published: 2006